Emerging Medical Technology – Trademark Portfolio

Entity Type: 03

Emerging Medical Technology holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 4 Nice Classification classes. The owner is based in encinitas, CA.

1660 neptune ave

encinitas, CA 92025

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PEP-PAK
PEP-PAK
Abandoned 2011

Trademark Classifications

Emerging Medical Technology's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Emerging Medical Technology have?

Emerging Medical Technology has 2 U.S. trademarks filed with the USPTO.

What trademark classes does Emerging Medical Technology file in?

Emerging Medical Technology files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 18 (Leather Goods), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What is Emerging Medical Technology's trademark registration success rate?

Emerging Medical Technology has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.